by Nancy and Ian Ashken Investment Trust LLLP

Common Stock

Common Stock

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Nancy and Ian Ashken Investment Trust LLLP (formerly IGHA Holdings, LLLP) on May 7, 2025.

Represents the weighted average price of the shares sold on August 11, 2025. The prices of the shares sold pursuant to the transactions ranged from $35.00 to $35.04 per share. The Nancy and Ian Ashken Investment Trust LLLP, upon request, will provide the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.

The shares of Common Stock reported herein are held directly by the Nancy and Ian Ashken Investment Trust LLLP (formerly IGHA Holdings, LLLP), over which, through the general partner, Mr. Ashken has voting and dispositive power. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.

Represents the weighted average price of the shares sold on August 12, 2025. The prices of the shares sold pursuant to the transactions ranged from $34.99 to $35.47 per share. The Nancy and Ian Ashken Investment Trust LLLP, upon request, will provide the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.

Includes 3,810 shares (prior to giving effect to the Stock Dividend) of the Issuer's Common Stock transferred from the reporting person's directly held account on June 23, 2025.

The shares of Common Stock reported herein are held directly by the Ashken Trust, of which Mr. Ashken is the trustee and beneficiary. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.

Held jointly in an account by the Ashken Trust and the Nancy K. Ashken Living Trust.

The shares of Common Stock and Series A Preferred Stock are held directly by Mariposa Acquisition IV, LLC. The Nancy and Ian Ashken Investment Trust LLLP (formerly IGHA Holdings LLLP), the general partner of which is wholly-owned by The Ian G.H. Ashken Living Trust (the "Ashken Trust"), of which Mr. Ashken is the trustee and beneficiary, holds a limited liability company interest in Mariposa Acquisition IV, LLC and, as a result, may be deemed to have a pecuniary interest in 5,083 shares of Common Stock and 1,152,000 shares (after giving effect to the Stock Dividend) of Series A Preferred Stock held by Mariposa Acquisition IV, LLC. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.


The shares are represented by restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. 100% of the RSUs
are initially subject to vesting. One-sixteenth (6.25%) of the total RSUs will vest on August 15, 2025 and the remainder will vest in 15 equal quarterly installments (November, February, May, and
August) of one-sixteenth thereafter (6.25% of the total RSUs will vest per quarter), provided in each case that the grantee is providing Continuous Service (as defined in the 2019 Plan) to the Company.
Provided that if a quarterly vesting date occurs on any day that is not a trading day, the quarterly vesting date shall instead be the next trading day.


The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2025.

Represents the weighted average price. The shares were sold in multiple transactions ranging from $11.36 to $11.68, inclusive. Upon request by the Commission staff, the issuer or security holder of the issuer, the reporting person will provide information regarding the number of shares disposed at each separate price.

/s/Vivienne R. Schiffer, by Power of Attorney


Common Stock

Common Stock

Common Stock

Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2023.

Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2024.

Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2025.

/s/ Lily J. Lu, Attorney-in-Fact for Nimrata Hunt


Delivery of shares to The New York Times Company to satisfy tax withholding obligations related to the one-third vesting of stock-settled restricted stock units granted on August 10, 2023, under The New York Times Company 2020 Incentive Compensation Plan.

The reporting person disclaims beneficial ownership of these shares.

/s/ Scott Warren Goodman as Attorney-in-fact for David S. Perpich


The reporting person has reported the weighted average purchase price for the transaction reported on this line.  The range of prices for the reported transaction is $15.66 to $15.81.  The reporting person will provide, upon request by the Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.


Common Stock

Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

With tandem dividend equivalent rights and tax withholding rights.

Includes 188 dividend equivalent units that had accrued on the restricted stock units.

The restricted stock units were granted on August 11, 2023 and vest in three equal installments on the first, second and third anniversaries of the grant date, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. The first and second installments (including the related dividend equivalent units) vested on August 11, 2024 and 2025, respectively.


Common Stock

Common Stock

Common stock

Common stock

Common stock

Common stock

Common stock

Common stock

Common stock

DRIP acquisition exempt from Section 16 reporting being reported voluntarily

500 shares vest on 10/24/2018, 10/24/2019, 10/24/2020 and 10/24/2021

500 shares vest on 11/15/2019, 11/15/2020, 11/15/2021 and 11/15/2022

500 shares vest on 11/28/2020, 11/28/2021, 11/28/2022 and 11/28/2023

500 shares vest on 11/20/2021, 11/20/2022, 11/20/2023 and 11/20/2024

500 shares vest on 10/26/2022, 10/26/2023, 10/26/2024 and 10/26/2025

500 shares vest on 11/17/2023, 11/17/2024, 11/17/2025 and 11/17/2026

500 shares vest on 11/16/2024, 11/16/2025, 11/16/2026 and 11/16/2027

500 shares vest on 11/15/2025, 11/15/2026, 11/15/2027 and 11/15/2028

500 shares vest on 11/20/2026, 11/20/2027, 11/20/2028 and 11/20/2029

Matt Snyder, by Power of Attorney from Thomas J. Carlson


Common Stock

Includes 166 dividend equivalent units that had accrued on the restricted stock units.

The restricted stock units were granted on August 11, 2023 and vest in three equal installments on the first, second and third anniversaries of the grant date, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. The first and second installments (including the related dividend equivalent units) vested on August 11, 2024 and 2025, respectively.


Common Stock

Includes 39 dividend equivalent units that had accrued on the restricted stock units.

The restricted stock units were granted on August 11, 2023 and vest in three equal installments on the first, second and third anniversaries of the grant date, subject to Ms. Thuerk's continued employment with the Company on the applicable vesting date. The first and second installments (including the related dividend equivalent units) vested on August 11, 2024 and 2025, respectively.


The price reported in column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $62.12 to $62.64, inclusive. The reporting person undertakes to provide to The Carlyle Group Inc., any security holder of The Carlyle Group Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.

The price reported in column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $62.715 to $63.71, inclusive. The reporting person undertakes to provide to The Carlyle Group Inc., any security holder of The Carlyle Group Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.

The price reported in column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $63.72 to $64.71, inclusive. The reporting person undertakes to provide to The Carlyle Group Inc., any security holder of The Carlyle Group Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.

The price reported in column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $64.72 to $64.92, inclusive. The reporting person undertakes to provide to The Carlyle Group Inc., any security holder of The Carlyle Group Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.

/s/ Anne K. Frederick by power of attorney for Jeffrey W. Ferguson


Reflects a charitable donation by the Reporting Person.

/s/ Anne K. Frederick, by Power of Attorney for William E. Conway, Jr.


Class A Common Stock

As part of the transactions effected on August 11, 2025, the Baiju Prafulkumar Bhatt Living Trust, dated 11/30/2017 ("Living Trust") donated an aggregate of 951,792 shares of its Class B Common Stock, resulting in an automatic conversion of the same amount of shares into Class A Common Stock upon execution of the donation.

Represents a bona fide gift of 951,792 shares from the Living Trust to a donor advised fund.

/s/ Matthew Yorkavich, attorney-in-fact for Baiju Bhatt


Common stock

Common stock

Common stock

Common stock

Common stock

Common stock

Common stock

Common stock

DRIP acquisition exempt from Section 16 reporting being reported voluntarily

500 shares vest on 11/15/2019, 11/15/2020, 11/15/2021 and 11/15/2022

500 shares vest on 11/28/2020, 11/28/2021, 11/28/2022 and 11/28/2023

500 shares vest on 11/20/2021, 11/20/2022, 11/20/2023 and 11/20/2024

500 shares vest on 10/26/2022, 10/26/2023, 10/26/2024 and 10/26/2025

500 shares vest on 11/17/2023, 11/17/2024, 11/17/2025 and 11/17/2026

500 shares vest on 11/16/2024, 11/16/2025, 11/16/2026 and 11/16/2027

500 shares vest on 11/15/2025, 11/15/2026, 11/15/2027 and 11/15/2028

500 shares vest on 11/20/2026, 11/20/2027, 11/20/2028 and 11/20/2029

Matt Snyder, by Power of Attorney from Douglas M. Pitt


Common Stock

Common Stock

Common Stock

Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $91.91 to $92.91. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $91.38 to $91.89. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $92.045 to $93.04. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

This option is fully vested and exercisable.

This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.


Non-qualified Stock Option (Right to Buy)

Common Stock

As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025.

Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $227.2792 to $227.7581 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $228.3200 to $229.1638 inclusive.  The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $229.3990 to $230.2300 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $230.4670 to $231.4356 inclusive.  The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $231.4772 to $232.4666 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $232.5000 to $233.4400 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Shares held in the Marc Benioff Fund LLC (the "Fund").  Fund interests are held in the reporting person's name or in trust.

Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

/s/ Andrew Leeds, Attorney-in-Fact for Marc Benioff


Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The RSUs will vest on the earliest of (i) the end of the reporting person's service on the board of directors of Trulieve, (ii) a change of control of Trulieve, or (iii) December 1, 2031.


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2024.

Includes 1,448 shares acquired under the issuer's employee stock purchase plan on May 14, 2025.

/s/ Lina Davidian as attorney-in-fact for Christian Ruppel


Common stock

Common stock

Common stock

DRIP acquisition exempt from Section 16 reporting being reported voluntarily

500 shares vest on 11/16/2024, 11/16/2025, 11/16/2026 and 11/16/2027

500 shares vest on 11/15/2025, 11/15/2026, 11/15/2027 and 11/15/2028

500 shares vest on 11/20/2026, 11/20/2027, 11/20/2028 and 11/20/2029

Matt Snyder, by Power of Attorney from Steven D Edwards


Common Stock

Common Stock

Common Stock

Represents securities directly owned by PFC SICAV. Pale Fire Capital, as the controlling person and sole shareholder of PFC SICAV, may be deemed to beneficially own the securities directly owned by PFC SICAV. Mr. Barta, as a control person and Chairman of the supervisory board of Pale Fire Capital, may be deemed to beneficially own the securities directly owned by PFC SICAV. Mr. Senkypl, as a control person and Chairman of the board of Pale Fire Capital, may be deemed to beneficially own the securities directly owned by PFC SICAV.

Represents securities directly owned by Pale Fire Capital. Mr. Barta, as a control person and Chairman of the supervisory board of Pale Fire Capital, may be deemed to beneficially own the securities directly owned by Pale Fire Capital. Mr. Senkypl, as a control person and Chairman of the board of Pale Fire Capital, may be deemed to beneficially own the securities directly owned by Pale Fire Capital.

Each performance stock unit represents a contingent right to receive one share of Common Stock.

The number of shares of Common Stock that will be acquired on vesting of the performance shares is contingent upon the achievement of pre-established stock price hurdles over a three-year performance period beginning on May 1, 2024, and ending on May 1, 2027; and achievement of continued service conditions measured on each of May 1, 2025, May 1, 2026, and May 1, 2027. The performance shares shall vest immediately upon certification of the achievement of both conditions by the compensation committee of the Issuer.

Reflects forfeiture of 5,750 PSUs originally granted May 1, 2024, due to the 5% reduction under the vesting-modifier performance metric.

This grant was approved by the compensation committee of the board of directors of the Issuer on Aug 11, 2025. The number of shares of Common Stock that will be acquired on vesting of the performance shares is contingent upon the remediation of material weakness over a two-year performance period beginning on May 1, 2025, and ending on May 1, 2027; and achievement of continued service conditions measured on each of May 1, 2026, and May 1, 2027. The performance shares shall vest immediately upon certification of the achievement of both conditions by the compensation committee of the Issuer.

/s/ Kevin McCormick, by Power of Attorney


Delivery of shares to The New York Times Company to satisfy tax withholding obligations related to the one-third vesting of stock-settled restricted stock units granted on August 10, 2023, under The New York Times Company 2020 Incentive Compensation Plan.

/s/ Michael A. Brown, Attorney-in-fact for William Bardeen


/s/ Andrew E. Loope as power of attorney


This transaction was originally reported in a Form 4 filed on November 21, 2024 (the "Original Form 4"). This transaction is being re-reported in this Form 4 to correct that the securities acquired in the transaction are beneficially owned by the reporting person indirectly through the Thronson Family Trust UA; the securities were incorrectly reported in the Original Form 4 as being directly owned by the reporting person due to a clerical error.


Represents an open market purchase of 700 shares at a price of $1.70 per share.

Represents an open market purchase of 5,000 shares at a price of $1.75 per share.

/s/ Veronica Gonzalez, as attorney-in-fact


Common Stock, par value $0.0001 per share

Common Stock

Common Stock

Shares surrendered to pay tax liability due on vesting of Restricted Stock Units

Each restricted stock unit represents a contingent right to receive one share of PHLT's common stock. The units were awarded at no cost to the Reporting Person.

Restricted Stock Unit award was granted on August 8, 2022 (the "Grant Date"). The Restricted Stock Units will vest in four equal installments on the first day of the next open trading window immediately following the first, second, third and fourth anniversaries of the Grant Date provided that the Reporting Person remains in continuous service through each vest date, subject to vesting acceleration pursuant to the terms of the Reporting Person's Change in Control and Severance Agreement.

Restricted Stock Unit Award was granted on August 5, 2024 (the "Grant Date"). The Restricted Stock Units will vest in four equal installments on the first day of the next open trading window immediately following the first, second, third and fourth anniversaries of the Grant Date provided that the Reporting Person remains in continuous service through each vest date, subject to vesting acceleration pursuant to the terms of the Reporting Person's Change in Control and Severance Agreement.

/s/ Rohit Ramchandani, Attorney-in-Fact for Simeon M. Kohl


Common Stock

Common Stock

Common Stock

Common stock

Common stock

Common stock

Common stock

Common Stock

Common stock

DRIP acquisition exempt from Section 16 reporting being reported voluntarily

1,500 shares vest on 10/24/2018, 10/24/2019, 10/24/2020 and 10/24/2021

1,500 shares vest on 11/15/2019, 11/15/2020, 11/15/2021 and 11/15/2022

1,750 shares vest on 11/28/2020, 11/28/2021,  11/28/2022 and 11/28/2023

1,750 shares vest on 11/20/2021, 11/20/2022, 11/20/2023 and 11/20/2024

1,875 shares vest on 10/26/2022, 10/26/2023, 10/26/2024 and 10/26/2025

1,938 shares vest on 11/17/2023 and 11/17/2024, and 1,937 shares vest on 11/17/2025 and 11/17/2026

1,950 shares vest on 11/16/2024, 11/16/2025, 11/16/2026 and 11/16/2027

1,950 shares vest on 11/15/2025, 11/15/2026, 11/15/2027 and 11/15/2028

1,950 shares vest on 11/20/2026, 11/20/2027, 11/20/2028 and 11/20/2029

Matt Snyder, by Power of Attorney from Joseph W. Turner


These transactions were executed in multiple trades at prices ranging from $7.31 to $7.32. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Represents 17,879 Restricted Stock Units.

Power of Attorney is attached hereto as Exhibit 24.


The price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $208.1150 through $208.8050 inclusive. The reporting person undertakes to provide Assurant, Inc., any security holder of Assurant, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to Form 4.

Includes restricted stock units.


Robert B. Goldberg, under power of attorney


Common Stock

Common Stock

Shares surrendered to pay tax liability due on vesting of Restricted Stock Units

Each restricted stock unit represents a contingent right to receive one share of PHLT's common stock. The units were awarded at no cost to Reporting Person.

Restricted Stock Unit award was granted on August 8, 2022 (the "Grant Date"). The Restricted Stock Units will vest in four equal installments on the first day of the next open trading window immediately following the first, second, third and fourth anniversaries of the Grant Date provided that the Reporting Person remains in continuous service through each vest date, subject to vesting acceleration pursuant to the terms of the Reporting Person's Change in Control and Severance Agreement.

Restricted Stock Unit Award was granted on August 5, 2024 (the "Grant Date"). The Restricted Stock Units will vest in four equal installments on the first day of the next open trading window immediately following the first, second, third and fourth anniversaries of the Grant Date provided that the Reporting Person remains in continuous service through each vest date, subject to vesting acceleration pursuant to the terms of the Reporting Person's Change in Control and Severance Agreement.


The units were transferred from the reporting person and gifted to trusts for the benefit of family members.


Common Stock

Common Stock

Common Stock

Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. This is not an open market sale of securities.

Each performance stock unit represents a contingent right to receive one share of Common Stock.

The number of shares of Common Stock that will be acquired on vesting of the performance shares is contingent upon the achievement of pre-established stock price hurdles over a three-year performance period beginning on May 1, 2024, and ending on May 1, 2027; and achievement of continued service conditions measured on each of May 1, 2025, May 1, 2026, and May 1, 2027. The performance shares shall vest immediately upon certification of the achievement of both conditions by the compensation committee of the Issuer.

Reflects forfeiture of 2,157 PSUs originally granted May 1, 2024, due to the 5% reduction under the vesting-modifier performance metric.

This grant was approved by the compensation committee of the board of directors of the Issuer on August, 11 2025. The number of shares of Common Stock that will be acquired on vesting of the performance shares is contingent upon the remediation of material weakness over a two-year performance period beginning on May 1, 2025, and ending on May 1, 2027; and achievement of continued service conditions measured on each of May 1, 2026, and May 1, 2027. The performance shares shall vest immediately upon certification of the achievement of both conditions by the compensation committee of the Issuer.


Per share value is based on the market closing price of the common shares for January 29, 2025.

This amendment is being filed to correct an error in the number of securities beneficially owned following the reported transaction. The ending balance originally reported was 177,433 shares. The correct number is 176,433 shares. This error also impacted the Reporting Person's Form 4 filing made on July 1, 2025. Subsequent Form 4 filings will reflect the corrected balance.


The shares covered herein were disposed of pursuant to a registered secondary offering (the  "Offering") contemplated by the prospectus included in the Issuer's registration statement on Form S-3, as originally filed on Form S-1 (File No. 333-261810).

The price of $8.9197 represents the $9.34 secondary public offering price per share, less the underwriting discounts and commissions of $0.4203 per share, for shares sold in connection with the Offering.

Held by Aldel LLC. The Reporting Person is the manager of Aldel LLC and has voting and investment discretion with respect to the securities held of record by Aldel LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

The shares covered herein were disposed of in connection with the exercise in full of the option to purchase additional shares granted to the underwriters pursuant to the underwriting agreement for the Offering.


Common stock

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

The restricted stock units were granted on August 11, 2022. Beginning on August 11, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.

/s/ William Cook, as attorney-in-fact for Rahul Ballal


Common stock

/s/ William Cook, as attorney-in-fact for Cynthia Smith


This transaction was originally reported in a Form 4 filed on November 21, 2024 (the "Original Form 4"). This transaction is being re-reported in this Form 4 to correct the amount of securities acquired in the transaction, which was incorrectly reported in the Original Form 4 due to a clerical error.


Represents interests in an issuer stock fund.

/s/ David S. Maltz, attorney-in-fact-for Thomas Preston Gillespie, Jr.


The reported shares of Class A Common Stock are within 372,500 of the Issuer's Private Placement Units, as described under the heading "Description of Securities" in the Issuer's registration statement on Form S-1 (File No. 333-288914), purchased by Highview Sponsor Co., LLC (the "Sponsor") for $10.00 per Private Placement Unit.

The Sponsor is the record holder of the shares reported herein. David Boris is the managing member of the Sponsor. As such, David Boris may be deemed to have beneficial ownership of the securities held directly by the Sponsor. Each such entity or person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.91 to $24.00. inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (3) to this Form 4.

The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

The shares are held directly by Frazier Lifesciences Sponsor LLC. The sole member of Frazier Lifesciences Sponsor LLC is Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

/s/ 	Steve R. Bailey, Attorney-in-Fact For James N. Topper


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 20, 2024.

The price reported in column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $1.90 to $2.02, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

The reporting person owns the securities indirectly through GOHO, LLC, of which Mr. Goldsteen is the sole managing member. Mr. Goldsteen disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

The price reported in column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $1.94 to $2.01, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

The price reported in column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $1.94 to $2.17, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

/s/ John Carpenter, Power of Attorney for Mitchell B. Goldsteen


Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The RSUs will vest on the earliest of (i) the end of the reporting person's service on the board of directors of Trulieve, (ii) a change of control of Trulieve, or (iii) December 1, 2031.

The reporting person also holds the following securities of the issuer: 15,000 Multiple Voting Shares held directly. Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis (or into an aggregate of 1,500,000 Subordinate Voting Shares).


Common Stock

Shares subject to the option vest in 36 equal monthly installments beginning on September 12, 2025.


The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on August 9, 2025 of 3,167 restricted stock units held by the reporting person.

/s/Ephraim Starr, Attorney-in-fact for Ginger Zhou


By; DAWN HALKUFF REVOCABLE TRUST U/A DTD 08/25/2017

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.190 to $7.450, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.


/s/ Leena Mansharamani, Attorney in Fact


Common Stock

These shares were awarded by the Board of Directors on August 11, 2025, as the Company had agreed to review the equity compensation for senior management within one year of the June 18, 2024 closing date of the acquisition of Lyneer Investments LLC.

This award does not have an expiration date.


Common Stock

Mr. Jagid gifted 200,000 shares of common stock to each of his two brothers Jonathan Jagid and Joshua Jagid in transactions that were exempt from regulation under Section 16(b).


/s/ Tiffany Meriweather, Attorney in Fact


Common Stock, par value $0.00001 per share

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on December 2, 2024.

The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of all the reported shares for purposes of Section 16 or for any other purpose.

/s/ Brady Duane Kafka, as Attorney-in-Fact


/s/Ephraim Starr, Attorney-in-fact for Olga Pirogova


These shares were purchased in connection with a dividend reinvestment through brokerage accounts.

These securities are held by a family limited partnership, of which the Reporting Person is a general partner.

The Reporting Person disclaims beneficial ownership of the securities reported on this form as indirectly beneficially owned except to the extent of her pecuniary interest.


The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 25, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. All sales by the reporting person are subject to the Issuer's equity ownership requirements.

Includes restricted stock awards vesting as to (i) 155,950 shares on January 25, 2026, (ii) 90,787 shares on January 25, 2027 and (iii) 35,941 shares on January 25, 2028.

/s/ Marci Frankenthaler, Attorney-in-Fact


This transaction was executed pursuant to a trading plan entered into by the reporting person on May 13, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Includes shares acquired by the reporting person through the Company's Associate Stock Purchase Plan since the last reported transaction.


The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.10 to $19.30, inclusive. The reporting person undertakes to provide CompoSecure, Inc. (the "Issuer"), any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

/s/ Kevin M. Moriarty, by attorney-in-fact Steven J. Feder


These securities are held by accounts managed by GoldenTree Asset Management LP. GoldenTree Asset Management LLC (the "General Partner") is the general partner of GoldenTree Asset Management LP. Steven A. Tananbaum is the managing member of the General Partner. Accordingly, each of the foregoing entities and Steven A. Tananbaum may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of their pecuniary interest therein, if any.

The securities are held of record by GoldenVest LLC. Steven A. Tananbaum is the managing member of GoldenVest LLC and therefore may be deemed to share beneficial ownership of the securities held of record by GoldenVest LLC. Steven A. Tananbaum disclaims any such beneficial ownership except to the extent of his pecuniary interest therein, if any.


The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.03 to $9.07 per share, inclusive. The Reporting Person
undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price
within the ranges set forth in this footnote.


The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.01 to $9.13 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.


Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. 50% of the RSUs will vest on December 1, 2026, and the remaining 50% of the RSUs will vest on December 1, 2027.

The reporting person also holds the following securities of the issuer: (i) 159,867 Multiple Voting Shares held directly, (ii) 9,867 Multiple Voting Shares held by Traunch IV LLC ("Traunch IV"), over which the reporting person may be deemed to exercise voting and investment control, and (iii) stock options to acquire 772,495 Subordinate Voting Shares vested as of December 1, 2024 held directly. Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis (or into an aggregate of 16,973,400 Subordinate Voting Shares). The reporting person disclaims beneficial ownership of the Multiple Voting Shares (and the Subordinate Voting Shares into which they are convertible) held by Traunch IV, except to the extent of her pecuniary interest therein.


Gift of shares to a donor advised fund. Mr. Reinhardt has no beneficial interest, control, or dispositive power over the gifted shares.


The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.05 to $9.07 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.


The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $18.68 to $18.83, inclusive. The reporting person undertakes to provide CompoSecure, Inc. (the "Issuer"), any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Includes (A) 323,378 shares of Class A Common Stock owned by the reporting person, (B) 48,071 shares of Class A Common Stock underlying restricted stock units ("RSUs"), which will vest in three equal installments on February 26, 2028, February 26, 2030, and February 26, 2032, (C) 62,500 shares of Class A Common Stock underlying RSUs that will vest on January 1, 2026, (D) 30,561 shares of Class A Common Stock underlying RSUs that will vest on January 1, 2026, and (E) 81,438 shares of Class A Common Stock underlying RSUs that will vest ratably on each of January 1, 2026 and January 1, 2027, subject in each case to the reporting person's continued service as of the applicable vesting date. The RSUs will be settled into Class A Common Stock upon vesting and may be settled net of shares withheld to pay applicable taxes.

Includes 213,841 performance-vesting RSUs, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the respective governing award agreement, subject to the reporting person's continued service as of the applicable vesting date. The RSUs will be settled into Class A Common Stock upon vesting and may be settled net of shares withheld to pay applicable taxes.

/s/ Timothy Fitzsimmons, by attorney-in-fact Steven J. Feder


This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.07 to $22.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


The reporting person also holds the following securities of the issuer: (i) 22,635 Multiple Voting Shares held by the JASON B PERNELL TR KFP IRREVOCABLE TRUST DTD 03/02/2020, over which the reporting person may be deemed to exercise voting and investment control, and (ii) 22,636 Multiple Voting Shares held by the KATHRYN FIELD PERNELL & TY ROOFNER TR JBP 2020 IRREVOCABLE TRUST DTD 01/06/2020, over which the reporting person may be deemed to exercise voting and investment control. Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis (or into an aggregate of 4,527,100 Subordinate Voting Shares).


Exhibit 24: Power of Attorney is attached.

/s/ Phillip D. Torrence, by Power of Attorney


By Capital Latinoamericano, S.A. de C.V.

By Promotora de Inversiones CapLat Espana, S.L.

Common Stock

Common Stock

Common Stock

Common Stock

This transaction is exempted under Rule 16b-6(b).

Pursuant to a Securities Purchase Agreement dated as of December 23, 2024 (the "SPA"), Capital Latinoamericano, S.A. de C.V. ("CapLat") CapLat exercised its right to acquire 489,279 shares of the issuer's common stock.

The reporting person is a sole member and manager of CapLat. The reporting person disclaims any beneficial ownership of any shares held by CapLat except to the extent of his ultimate pecuniary interest.

The price in Column 4 is a weighted average sale price. The prices actually received ranged from $1.6935 to $1.7456. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

The price in Column 4 is a weighted average sale price. The prices actually received ranged from $1.70 to $1.7039. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Pursuant to a Contribution Agreement dated as of July 29, 2025, CapLat transferred all of its right title and interest in 1,991,998 shares of the issuer's common stock to its wholly owned subsidiary, Promotora de Inversiones Caplat Espana S.L. ("CapLat Espana").

The reporting person is the sole manager of CapLat Espana. The reporting person disclaims any beneficial ownership of any shares held by CapLat Espana except to the extent of his ultimate pecuniary interest.

Pursuant to the SPA, and an assignment agreement between CapLat and CapLat Espana dated July 25, 2025 (the "Assignment"), CapLat Espana exercised its right to acquire 1,939,468 shares of the issuer's common stock.

Pursuant the Assignment, CapLat assigned all of its right, title and interest in its option to purchase the issuer's shares of common stock to CapLat Espana.

/s/ Juan Antonio Carlos Cortina Gallardo


Exhibit List: Exhibit 24 - Power of Attorney


By the Bobak Azamian Living Trust established April 16, 2018

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024.

The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.


Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. 50% of the RSUs will vest on December 1, 2026, and the remaining 50% of the RSUs will vest on December 1, 2027.


Ordinary Shares - Restricted Stock Units

Ordinary Shares

Ordinary Shares

Ordinary Shares

End-of-period holdings include monthly purchases under the nVent Electric plc Employee Stock Purchase Plan (ESPP) in exempt transactions pursuant to Rule 16b-3(c).

End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a).

Shares swapped to cover the stock option exercise prices resulting from the stock option exercises.

Shares of nVent Electric plc will be delivered to the reporting person in accordance with their irrevocable deferral election.

This option is presently exercisable in full.

/s/ John K. Wilson, Attorney-in-Fact for Aravind Padmanabhan


Class B Common Stock

Class A Common Stock

Class A Common Stock

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

Shares sold pursuant to a 10b5-1 plan dated September 13, 2024.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $128.51 to $129.50. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $129.61 to $130.59. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $130.61 to $131.57. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $131.76 to $132.50. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Option is fully vested and exercisable.


Common Stock, par value $0.01

Restricted stock units granted pursuant to the Dana Incorporated 2021 Omnibus Incentive Plan.

Each restricted stock unit granted represents the right to receive one share of Dana common stock or, at the election of Dana, cash equal to the market value per share.  Each restricted stock unit contains dividend equivalent rights.

Restricted stock units granted vest in three (3) equal annual installments beginning on the first anniversary date of the grant.

/s/ Laura L. Aossey on behalf of James D. Kellett


Such shares were sold to the Issuer in an exempt transaction pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended, pursuant to the terms of the Second Amended and Restated Stockholders Agreement, dated as of May 23, 2015, as amended, by and among, among others, the Issuer, Advance/Newhouse Partnership and the Reporting Person, the letter agreement, dated February 23, 2021, between the Issuer and the Reporting Person, and Amendment No. 1 to the Second Amended and Restated Stockholders Agreement and the Letter Agreement, dated as of November 12, 2024, by and among, among others, the Issuer and the Reporting Person.

Liberty Broadband Corporation By: /s/ Brittany A. Uthoff; Name: Brittany A. Uthoff; Title: Vice President


Class A Common Stock

Class A Common Stock

The shares underlying the option are fully vested.

The reported transaction involves the reporting person's transfer of option to his irrevocable trust.


The price reported is the average trading price of the shares sold. The shares were sold in multiple transactions at prices ranging from $142.05 to $142.435, inclusive. Upon request, the reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes restricted stock units that will vest on November 1, 2025 and that will settle in shares of Lindsay Corporation's common stock on a deferred one-for-one basis.

Includes restricted stock units that have vested but receipt and settlement of which have been deferred under the Lindsay Corporation Directors Nonqualified Deferred Compensation Plan.

The price reported is the average trading price of the shares sold. The shares were sold in multiple transactions at prices ranging from $142.00 to $142.185, inclusive. Upon request, the reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Shares are held by Kiroki Investments, LLC, a limited liability company of which the reporting person is the sole manager and over which the reporting person has sole voting and investment power.


Class A Common Stock

Option granted under the Company's 2009 Omnibus Incentive Plan.


Common Stock

Restricted shares granted pursuant to Cintas Corporation Equity Compensation Plan.

The options vest as follows: one-third on the third anniversary date of the grant date, one-third on the fourth anniversary of the grant date, and one-third on the fifth anniversary of the grant date.

/s/ Allison A. Westfall as Attorney-in-Fact for D. Brock Denton


Common Stock

Restricted stock units that vest 25% on each anniversary of the grant date

Stock options that vest 25% on the first annual anniversary of the date of grant and then 1/48th per month thereafter.


By Limited Liability Limited Partnership

Owned by a limited liability limited partnership of which Mr. Farmer has sole voting and dispositive power. The Reporting Person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.

Owned by limited liability companies of which Mr. Farmer has sole voting and dispositive power. The Reporting Person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.

Owned by trusts for the benefit of Mr. Farmer and his family. The Reporting Person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.

Owned by a limited partnership under Mr. Farmer's control. The Reporting Person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted March 17, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.86 to $16.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.86 to $17.31 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.


Executive Vice President, Chief Commercial Officer


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

The options vest as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date and one-third on the fifth anniversary of the grant date.

/s/ Allison A. Westfall as Attorney-in-Fact for Jim Rozakis


The sale reported was effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on May 13, 2025.


Reflects the weighted average price of 5,713 shares of common stock of C.H. Robinson Worldwide, Inc. sold by the reporting person in multiple transactions on August 11, 2025 with sale prices ranging from $116.11 to $116.48 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price

Included in this amount are 65,459 shares of Issuer common stock issuable in settlement of an equal number of restricted stock units and deferred shares credited to the reporting person's NQDC Plan account and 269 shares held directly by the reporting person..

/s/ Nicole Strydom, Attorney-in-Fact for Angela K. Freeman


Common Stock

Each share of phantom stock represents the right to receive one share of Common Stock.

The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company.

/s/ Christine Dryden, Attorney-in-Fact for Kim K.W. Rucker


Shares withheld by the Company to satisfy tax withholding obligations related to the 2024 RSUs that vested on August 11, 2025.

Exhibits: Exhibit 24 - Power of Attorney

Phillip J. Platt By: Mavis Huger as Attorney-in-Fact


Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. 50% of the RSUs will vest on December 1, 2026, and the remaining 50% of the RSUs will vest on December 1, 2027.


Includes shares acquired though issuer's dividend reinvestment plan.

Reporting person is a director of the Gould Shenfeld Family Foundation. Includes shares obtained through issuer's dividend reinvestment plan.

Reporting person is a trustee of the Gould Family Trust, which owns these shares. Includes shares obtained through issuer's dividend reinvestment plan.

Reporting person is a manager of 130 Store Company LLC. Reporting person disclaims a beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.

Reporting person is an officer of the managing general  partner of Gould Investors L.P.  These shares represent all shares of the issuer owned by Gould Investors L.P., including shares in which the reporting person does not have a pecuniary interest.  Includes shares obtained through issuer's dividend reinvestment plan.

This transaction was executed in multiple trades at prices ranging from $14.86 to $14.9396. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $14.895 to $14.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

/s/ Jeffrey A. Gould by Isaac Kalish, his attorney in fact


Gould Investors L.P. by Georgetown Partners LLC, by Mark Lundy, President


Includes shares acquired through issuer's dividend reinvestment plan.

Reporting person is a trustee of the Gould Family Trust, which owns these shares. Includes shares acquired through issuer's dividend investment plan.

Reporting person is a trustee of the Gould Shenfeld Family Foundation. Includes shares acquired through issuer's dividend investment plan.

Reporting person is a trustee of BRT Apartments Corp. Pension Trust, which owns these shares.

Reporting person is an officer of the managing general partner of Gould Investors L.P.  These shares represent all shares of the issuer owned by Gould Investors L.P., including shares in which the reporting person does not have a pecuniary interest.  Includes shares obtained through issuer's dividend reinvestment plan.

/s/ Matthew J. Gould by Isaac Kalish, his attorney in fact


Common Stock

/s/ Christine Dryden, Attorney-in-Fact for Deborah J. Kissire


Common Stock

/s/ Christine Dryden, Attorney-in-Fact for Jay V. Ihlenfeld


Date of Rule 10b5-1 plan adoption: 03/14/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.42 to $14.61. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

/s/ Christopher J. Joyce, as Attorney-in-Fact, for Hyong (Ken) Kim


On August 12, 2025, 10,132 shares were distributed from a family trust to a child of the reporting person.


Common Stock

Each share of phantom stock represents the right to receive one share of Common Stock.

The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company.

/s/ Christine Dryden, Attorney-in-Fact for Kathryn Hill


/s/ Stephen Chen, as Attorney-in-Fact for Natalie Glance


Common Stock

/s/ Christine Dryden, Attorney-in-Fact for Timothy Go


Represents the number of shares sold by the Reporting Person to satisfy the Reporting Person's tax obligations resulting from the settlement of vested RSUs on May 22, 2025.

All shares sold at an exact price of $8.6475.

/s/ Richard S. Lindahl, Attorney-in-fact


Common Stock

/s/ Christine Dryden, Attorney-in-Fact for Edward G. Galante


/s/ Kevin McCormick, by Power of Attorney


Date of Rule 10b5-1 plan adoption: 03/12/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.42 to $14.80. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

/s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao


Restricted shares granted pursuant to Cintas Corporation Equity Compensation Plan.

/s/ Allison A. Westfall as Attorney-in-Fact for Todd M. Schneider


Motorola Solutions, Inc. - Common Stock

$459.9806 is the weighted average sales price. Prices for this transaction ranged from $459.78 to $460.27. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Includes shares acquired under the Motorola Solutions Employee Stock Purchase Plan and through the reinvestment of dividends.

These performance based stock options vested on March 8, 2024, upon the attainment of the satisfaction of certain financial performance objectives.

Alejandro Dieguez, on behalf of Cynthia M. Yazdi, Senior Vice President, Communications & Brand (Power of Attorney on File)


Common Stock

Common Stock

The Amount of Securities Beneficially Owned includes shares acquired pursuant to dividend reinvestments exempt from Section 16 pursuant to Rule 16a-11.

Represents weighted average price.  Individual sales by lot ranged from $138.16 to $139.115.  The Company will provide, upon request by the SEC staff, the full information regarding the number of shares purchased or sold at each separate price.

Option (right to buy) granted pursuant to the Company's Stock Plan.

Options vest in one-third (1/3) annual increments commencing on 11/20/2017.

Options vest in one-third (1/3) annual increments commencing on 11/19/2018.


Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock pursuant to the NiSource Inc. 2020 Omnibus Incentive Plan. Subject to certain forfeiture conditions, the RSUs will 100% vest on February 29, 2028, provided that the reporting person is continuously employed by the Company through and including that date.


$471.3518 is the weighted average sales price. Prices for this transaction ranged from $471.00 to $471.72. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

$470.7501 is the weighted average sales price. Prices for this transaction ranged from $470.50 to $470.995. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Alejandro Dieguez, on behalf of Jason J. Winkler, Executive Vice President and Chief Financial Officer (Power of Attorney on File)


The reporting person previously reported indirect beneficial ownership of these securities through his 100% ownership of C Digital Libraries Inc., which in turn beneficially owned Digital Knight Finance S.a.r.l. ("DKF"), the record holder of the issuer's shares. Effective August 8, 2025, the reporting person ceased to have any direct or indirect interests in DKF and therefore ceased to beneficially own the issuer's securities held by DKF.


/s/ Shannon C. Stanley, Attorney-in-fact


$460.5281 is the weighted average sales price. Prices for this transaction ranged from $460.48 to $460.595. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Alejandro Dieguez, on behalf of Kathryn A. Moore, Senior Vice President, Human Resources (Power of Attorney on File)


Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. 50% of the RSUs will vest on December 1, 2026, and the remaining 50% of the RSUs will vest on December 1, 2027.


Motorola Solutions, Inc. - Common Stock

Motorola Solutions Inc. - Common Stock

Motorola Solutions, Inc. - Common Stock

Motorola Solutions, Inc. - Common Stock

Motorola Solutions, Inc. - Common Stock

These options vested in three equal annual installments beginning on November 1, 2022.

These options vested in three equal annual installments beginning on March 10, 2023.

These options vest in three equal annual installments beginning on March 9, 2024.

These options vest in three equal annual installments beginning on March 14, 2025.

Alejandro Dieguez, on behalf of Katherine A. Maher, Corporate Vice President and Chief Accounting Officer (Power of Attorney on File)


The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Trustee of the Ronald O'Hanley Irrevocable Trust on February 27, 2025. See also Footnote 3.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.46 through $111.45, inclusive. The reporting person undertakes to provide to State Street Corporation, any security holder of State Street Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

By a trust. The reporting person continues to report beneficial ownership of STT common stock held by the trust but disclaims beneficial ownership except to the extent of his pecuniary interest therein.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.46 through $111.51 inclusive. The reporting person undertakes to provide to State Street Corporation, any security holder of State Street Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.


Common Stock

Restricted shares granted pursuant to Cintas Corporation Equity Compensation Plan.

The option vests as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date, and one-third on the fifth anniversary of the grant date.

/s/ Allison A. Westfall as Attorney-in-Fact for Scott Garula


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025.

This transaction was executed in multiple trades during the day at prices ranging from $162.44 to $163.41. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Shares are held by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.

This transaction was executed in multiple trades during the day at prices ranging from $163.51 to $164.19. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $157.36 to $158.34. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $159.41 to $160.40. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $160.42 to $161.39. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $161.44 to $162.43. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $158.38 to $159.26. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

/s/ Veena Bhatia, Attorney-in-Fact for Cannon-Brookes Michael


Represents shares surrendered by the Reporting Person for withholding of taxes pursuant to the terms of the Issuer's 2018 Equity Incentive Plan.

The price reported in Table I, Box 4 above reflects the actual per share sales price of the shares disposed.

/s/ J. Brendhan Botkin, Attorney-in-Fact


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 12, 2025.

Shares are held by Farquhar Investment Partnership No. 2.

/s/ Veena Bhatia, Attorney-in-Fact for Farquhar Scott


By: Gregory Scott Thomas attorney-in-fact For: Justin E. Dougherty


The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

Reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.01 to $17.08, inclusive. The Reporting Person will provide, upon the request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price

/s/ Scott Andreasen, as Attorney-in-Fact


Non-Employee Stock Option (right to buy)

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

25% per year for four years.


Grant of restricted stock award under the Issuer's 2025 Incentive Award Plan. The shares vest in quarterly installments over the three-year period following the grant, subject to the Reporting Person's continuous service as a board member through such date.

This restricted stock award was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an initial director equity grant.

Grant of restricted stock award under the Issuer's 2025 Incentive Award Plan. The shares vest in three installments with 1,125 shares vesting November 27, 2025, 960 shares vesting February 27, 2026 and 928 shares vesting May 27, 2026 or, if earlier for each installment, the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.

This restricted stock award was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant, prorated from the date of the Issuer's last annual meeting of stockholders.

/s/ Kelli Faerber, Attorney-in-Fact for Omar Tawakol


The transaction reported in this Form 4 reflects withholding of shares of common stock to satisfy tax withholding obligations resulting from the vesting of restricted stock.

Some of these shares are restricted shares that are subject to either time-vesting or performance-based restrictions.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Represents shares of common stock of the Issuer received on December 21, 2023, as consideration pursuant to that certain Merger Agreement, dated as of June 27, 2023 (as amended on September 22, 2023 and as may be further amended and/or restated from time to time, the "Merger Agreement"), by and among Airship AI Holdings, Inc., a Delaware corporation (the "Issuer") (formerly known as BYTE Acquisition Corp., a Cayman Island exempted company limited by shares, prior to its domestication as a Delaware corporation), BYTE Merger Sub, Inc., a Washington corporation and a direct, wholly-owned subsidiary of the Issuer, and Airship AI, Inc., a Washington company (formerly known as Airship AI Holdings, Inc., "Airship AI"). The Reporting Person received the reported shares in exchange for shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Airship Kirkland Family Limited Partnership is the record holder of the securities reported herein. Victor Huang is the managing partner of Airship Kirkland Family Limited Partnership and as such has voting and dispositive power over these securities. Mr. Huang disclaims beneficial ownership of the securities held by Airship Kirkland Family Limited Partnership, except to the extent of his pecuniary interest therein.

Represents options to purchase shares of common stock of the Issuer received on December 21, 2023, pursuant to the Merger Agreement, upon the conversion of options to purchase shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Represents stock appreciation rights denominated in shares of common stock of the Issuer received on December 21, 2023, pursuant to the Merger Agreement, upon the conversion of stock appreciation rights denominated in shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Represents warrants to purchase shares of common stock of the Issuer received by the Reporting Person on December 21, 2023, pursuant to the Merger Agreement, upon the conversion of warrants to purchase shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Pursuant to earnout provisions in the Merger Agreement, the holder of such Earnout Rights is entitled to receive shares of common stock of the Issuer upon the occurrence of certain operating performance and share price performance milestones during the applicable earnout periods set forth in the Merger Agreement.

Options vest quarterly over 4 years.

The Reporting Person files this Amendment No. 1 to its original Form 4 dated 01/07/2025 to correctly reflect the transaction and ending balance.


The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.


The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $31.80 to $31.83. The Reporting Person undertakes to provide to Allegro MicroSystems, Inc. ("ALGM"), any security holder of ALGM, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

/s/ Raymond Myer, Attorney-in-Fact for Richard R. Lury


The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

/s/ Jonathan Groff for Jacob Van Naarden, pursuant to authorization on file


Common Stock, par value $0.001 per share

Mr. Day is the co-trustee of The Day Family Trust, which owns the reported securities. Mr. Day disclaims beneficial ownership of shares of common stock held by The Day Family Trust, except to the extent of his pecuniary interest therein


This transaction was executed in multiple trades at prices ranging from $31.07 to $31.21; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

/s/ Martijn van Steenpaal, as Attorney-in-Fact for John F. Sterling


Shares were sold from the brokerage account in the name of Craig D. Smith TTEE Craig D. Smith TR dated May 8, 2003, U/A 5/8/03 FBO Craig D. Smith, where reporting person is the trustee and beneficiary.


These shares were sold in multiple transactions at prices ranging from $1.31 to $1.43, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Shares held by Luxor Capital LLC, which is wholly-owned by Mr. Goodman.


Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

One-third of the RSUs shall vest on each of August 1, 2026, August 1, 2027 and August 1, 2028.

/s/ Matthew R. St. Louis, Attorney-in-Fact for Kevin Thornal (power of attorney previously filed)


Represents a weighted average price. The shares were sold in multiple transactions at prices ranged from $238.96 to $239.95. The reporting person undertakes to provide the full information regarding the number of shares sold at each price to the Commission, the issuer or a security holder of the issuer upon request.

Represents a weighted average price. The shares were sold in multiple transactions at prices ranged from $239.965 to $240.90. The reporting person undertakes to provide the full information regarding the number of shares sold at each price to the Commission, the issuer or a security holder of the issuer upon request.

Represents a weighted average price. The shares were sold in multiple transactions at prices ranged from $241.14 to $242.01. The reporting person undertakes to provide the full information regarding the number of shares sold at each price to the Commission, the issuer or a security holder of the issuer upon request.

Represents a weighted average price. The shares were sold in multiple transactions at prices ranged from $242.47 to $243.04. The reporting person undertakes to provide the full information regarding the number of shares sold at each price to the Commission, the issuer or a security holder of the issuer upon request.


Common Stock

The option shall vest and become exercisable in 16 substantially equal quarterly installments after August 8, 2025, such that the award will be fully vested and exercisable on August 8, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date.


Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of performance stock units.

The weighted average sale price for the transaction reported was $17.3963, and the range of prices were between $16.40 and $18.47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.


Common Stock

The shares are held by a trust having an independent trustee ("Trust 1"). The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.

The shares are held by a trust having an independent trustee ("Trust 2"). The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.

The shares are held directly by Point Sur Investors Fund I, LP ("Point Sur LP"). The General Partner of Point Sur LP is Point Sur Investors LLC. The Reporting Person is a managing member of Point Sur Investors, LLC and as such has voting and dispositive power over the securities held by Point Sur LP. The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.

The shares are held directly by Point Sur Investors, LLC. The Reporting Person is a managing members of Point Sur Investors, LLC and as such has voting and dispositive power over the securities held by Point Sur Investors, LLC. The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.

President, Chief Operating Officer, Principal Financial Officer, and Principal Accounting Officer


Includes 500 shares that were acquired on May 15, 2025 under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Due to a scrivener's error on the Reporting Person's filing on December 2, 2024, the number of shares beneficially owned was inadvertently understated by one share. This amount lists the correct number of shares beneficially owned.


These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.45 to $339.70, inclusive. The reporting person undertakes to provide IES Holdings, Inc. ("IES"), any security holder of IES, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.


Eaton Vance Tax-Advantaged Global Dividend Income Fund


Transfer of shares to family trust.


Voting Common Stock

Voting Common Stock

Voting Common Stock

Voting Common Stock

Voting Common Stock

Voting Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Live Oak Bancshares, Inc. (the "Company") voting common stock.

The RSUs vest in five equal annual installments beginning on August 10, 2022, subject to the reporting person's continuous service to the Company or a related entity on such date.

The RSUs vest in five equal annual installments beginning on February 14, 2023, subject to the reporting person's continuous service to the Company or a related entity on such date.

The RSUs vest in five equal annual installments beginning on February 13, 2024, subject to the reporting person's continuous service to the Company or a related entity on such date.

The RSUs vest in five equal annual installments beginning on August 25, 2024, subject to the reporting person's continuous service to the Company or a related entity on such date.

The RSUs vest in five equal annual installments beginning on February 12, 2025, subject to the reporting person's continuous service to the Company or a related entity on such date.

The RSUs vest in five equal annual installments beginning on February 10, 2026, subject to the reporting person's continuous service to the Company or a related entity on such date.

/s/ Jonathan A. Greene, By Power of Attorney


Held by Mark E. Ferguson III Revocable Trust

This total reflects the acquisition of 39.02 Restricted Stock Units on 7/15/2025 pursuant to a dividend reinvestment feature of the PG&E Corporation 2021 Long Term Incentive Plan.

/s/ J. Ellen Conti, attorney-in-fact for Mark E. Ferguson III (signed power of attorney on file with SEC)


/s/ Jeremiah G. Garvey, Attorney-in-Fact for David R. Gaboury


Voting Common Stock

Voting Common Stock

Voting Common Stock

Voting Common Stock

Voting Common Stock

The RSUs vest in five equal installments beginning on February 12, 2025, subject to the reporting person's continuous service to the Company or a related entity on such date.


The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $3.25 to $3.32, inclusive.  The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form.


Common Stock

Common Stock

On August 11, 2022, Ms. Boyd was granted 2,893 restricted stock units ("RSUs"), vesting in one installment on the third anniversary of the grant date.

Each RSU represents a right to acquire one share of McDonald's Corporation common stock.

Settlement of dividend equivalent rights in connection with vested RSUs. Each dividend equivalent right is the economic equivalent of one share of McDonald's Corporation common stock.

/s/ Jeffrey J. Pochowicz, Attorney-in-fact


/s/ Thomas D. Scholtes, as Attorney-in-fact for Carol Lindstrom


Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on August 12, 2022.

/s/ Stephanie Meade, as Attorney-in-Fact for Kevin J. Khanna


Includes grant of 4,383 restricted share units as non-management trustee compensation. These restricted share units vest in full on the earlier of (i) one year from the date of grant or (ii) the date of the next annual meeting of shareholders.


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.28 to $99.27. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.28 to $100.27. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.28 to $101.27. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.28 to $102.03. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.67 to $98.66. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.67 to $99.42. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


This transaction was executed in multiple trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information
regarding the transactions.


Common Stock

This option vests as to 4,410 shares on each of 6/16/25 and 6/16/26 and 4,409 options vest on 6/16/27.

Edward Peilen as Attorney-in-Fact for Lisa Nettis pursuant to Power of Attorney filed herewith.


Class C Common Stock

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on January 13, 2025.

The options are fully vested.


The shares were sold in multiple transactions at prices ranging from $253.81 to $254.56, inclusive. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.


Shares issued under the Capital Southwest 2021 Non-Employee Director Restricted Stock Award Plan

Mr. Thomas is President and sole manager of Thomas Heritage Company, L.L.C., the sole general partner of Thomas Heritage Partners, Ltd. (the "Partnership"). In such capacity, Mr. Thomas has sole voting and dispositive power with respect to 571,939 shares owned by the Partnership.


Represents the grant of restricted stock units to the reporting person pursuant to the Littelfuse/IXYS Corporation Long-Term Incentive Plan. The grant vests in increments of one-third annually beginning on the first anniversary of the date of grant.


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.07 to $1.16, inclusive. The reporting person undertakes to provide to Dolphin Entertainment, Inc., any security holder of Dolphin Entertainment, Inc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the ranges set forth in this footnote (1) to this Form 4.

Dolphin Entertainment, LLC is an entity wholly owned by William O'Dowd IV.

Dolphin Digital Media Holdings LLC is an entity wholly owned by William O'Dowd IV.


Class A Common Stock

100% of the shares subject to the option are fully vested and exercisable.


Includes shares that have a time-based vesting provision.

Michael W. Metcalf, Power of Attorney for Terry B. McKertcher


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.01 to $21.47, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.31 to $22.205, inclusive.

/s/ Emmanuelle Lee, attorney-in-fact for Thomas D. Logan


Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.

/s/ Thomas D. Scholtes, as Attorney-in-fact for Thimaya K. Subaiya


Represents shares issued to the Reporting Person pursuant to the Issuer's 2024 Equity Incentive Plan.


Common Shares, par value $0.001 per share

Not applicable.

The total number of shares indirectly beneficially owned by the reporting person includes 4,036 shares, which were inadvertently omitted from the six prior Forms 4 filed by the reporting person from April 7, 2022 through March 24, 2025, due to a clerical error.


Common Stock

The reported securities were purchased by the reporting person at a combined purchase price for a share of common stock and accompanying warrant equal to $2.00 in connection with the issuer's public offering that closed on August 11, 2025.

Securities are held in the name of Do & Rickles Investments LLC.


Held by Frontier TopCo Partnership, L.P.

Consists of shares of common stock, par value $0.01 per share, of the Issuer ("Common Stock") held by the Reporting Person that were repurchased by the Issuer at the closing price per share on August 11, 2025.

Consists of shares of Common Stock held directly by Frontier TopCo Partnership, L.P. ("Kodiak Holdings"). Frontier TopCo GP, LLC ("Frontier GP") is the general partner of Kodiak Holdings. EQT Infrastructure III SCSp ("EQT Infrastructure III") indirectly owns 100% of the membership interests in Frontier GP. EQT Fund Management S.a r.l. ("EFMS") has exclusive responsibility for the management and control of the business and affairs of investment vehicles which constitute the majority of the total commitments to EQT Infrastructure III. As such, EFMS has the power to control Frontier GP's voting and investment decisions and may be deemed to have beneficial ownership of the securities held by Kodiak Holdings.

This filing shall not be deemed an admission that the Reporting Persons are beneficial owners of all securities covered by this filing for purposes of Section 16 of the Exchange Act or otherwise, and each Reporting Person disclaims beneficial ownership of these securities, except to the extent of such Reporting Person's pecuniary interest therein, if any.


Cusumano Dino M

C/O AIP 450 LEXINGTON AVENUE, 40TH FLOOR

These shares are held directly by Vertex Aerospace Holdco LLC ("Vertex Holdco"). AIPCF VI LLC ("AIP GP") is the general partner of American Industrial Partners Capital Fund VI, L.P. ("AIP Fund VI"), the managing member of AIP Vertex GP LLC, which is the general partner of AIPCF VI Vertex Aerospace Funding LP ("Vertex Funding"). Vertex Holdco is a direct, wholly owned subsidiary of Vertex Funding.

These shares are held directly by Lightship Capital LLC ("Lightship"). AIP GP is the general partner of AIPCF VI Credit Opportunity Fund, LP, which is the sole member of Lightship.

Any action by AIP GP with respect to these shares, including voting and dispositive decisions, requires a unanimous vote of the managing members of AIP GP. The Reporting Person is a senior managing member of AIP GP and also serves as a member of the Board of Directors of the Issuer. Accordingly, the Reporting Person may be deemed to share voting and dispositive power with respect to the shares held by Vertex Holdco and Lightship.

(Continued from Footnote 3) The Reporting Person disclaims beneficial ownership of the shares of common stock held by Vertex Holdco and Lightship, except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose.


These shares are held directly by Vertex Aerospace Holdco LLC ("Vertex Holdco"). AIPCF VI LLC ("AIP GP") is the general partner of American Industrial Partners Capital Fund VI, L.P. ("AIP Fund VI") and the managing member of AIP Vertex GP LLC, which is the general partner of AIPCF VI Vertex Aerospace Funding LP ("Vertex Funding"). Vertex Holdco is a direct, wholly owned subsidiary of Vertex Funding.

Any action by AIP GP with respect to these shares, including voting and dispositive decisions, requires a unanimous vote of the managing members of AIP GP. Mr. Dino Cusumano is a senior managing member of AIP GP and also serves as a member of the Board of Directors of the Issuer. Accordingly, Mr. Cusumano may be deemed to share voting and dispositive power with respect to the shares held by the Reporting Persons.

(Continued from Footnote 3) Mr. Cusumano disclaims beneficial ownership of the shares of common stock held by the Reporting Persons, except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose.